822 reports of this reaction
3.7% of all FESOTERODINE FUMARATE reports
#2 most reported adverse reaction
DRY MOUTH is the #2 most commonly reported adverse reaction for FESOTERODINE FUMARATE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 822 FDA adverse event reports linking FESOTERODINE FUMARATE to DRY MOUTH. This represents approximately 3.7% of all 22,165 adverse event reports for this drug.
Patients taking FESOTERODINE FUMARATE who experience dry mouth should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRY MOUTH is moderately reported among FESOTERODINE FUMARATE users, representing a notable but not dominant share of adverse events.
In addition to dry mouth, the following adverse reactions have been reported for FESOTERODINE FUMARATE:
The following drugs have also been linked to dry mouth in FDA adverse event reports:
DRY MOUTH has been reported as an adverse event in 822 FDA reports for FESOTERODINE FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRY MOUTH accounts for approximately 3.7% of all adverse event reports for FESOTERODINE FUMARATE, making it one of the most commonly reported side effect.
If you experience dry mouth while taking FESOTERODINE FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.